Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Β-LGND2
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Other names | β-LGND2; ER-β-selective ligand 2 |
Drug class | Nonsteroidal estrogen; Selective ERβ agonist |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
Chemical and physical data | |
Formula | C15H10BrNO4 |
Molar mass | 348.152 g·mol−1 |
3D model (JSmol) | |
| |
|
β-LGND2, also known as ERβ-selective ligand 2 or as GTx-878, is a synthetic nonsteroidal estrogen and selective ERβ agonist which was under development by GTx for the treatment of benign prostatic hyperplasia, prostatitis, and rheumatoid arthritis but was never marketed. It shows approximately 25-fold selectivity for activation of the ERβ over the ERα (EC50 = 2 nM and 52 nM, respectively). β-LGND2 is an isoquinolinone derivative.